RECURRENT BREAST CANCER
Clinical trials for RECURRENT BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT BREAST CANCER trials appear
Sign up with your email to follow new studies for RECURRENT BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested to control Tough-to-Treat breast cancer
Disease control Recruiting nowThis study is testing whether adding an experimental drug called alisertib to standard hormone therapy can better control advanced breast cancer that has stopped responding to previous hormone treatments. It will enroll about 150 adults whose cancer has returned or spread and aim…
Matched conditions: RECURRENT BREAST CANCER
Phase: PHASE2 • Sponsor: Puma Biotechnology, Inc. • Aim: Disease control
Last updated Mar 09, 2026 14:24 UTC
-
New hope for Tough-to-Treat breast cancer: First-Ever test of Two-Pronged attack
Disease control Recruiting nowThis early-stage study is testing the safety and effectiveness of combining two drugs, palbociclib and avelumab, for patients with advanced breast cancer. It focuses on a specific, hard-to-treat type called AR-positive triple-negative breast cancer. The goal is to see if this new…
Matched conditions: RECURRENT BREAST CANCER
Phase: PHASE1 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated Feb 25, 2026 15:06 UTC